GEP20063882B - Dosage regimen and pharmaceutical composition for emergency contraception - Google Patents

Dosage regimen and pharmaceutical composition for emergency contraception

Info

Publication number
GEP20063882B
GEP20063882B GE5567A GEAP2002005567A GEP20063882B GE P20063882 B GEP20063882 B GE P20063882B GE 5567 A GE5567 A GE 5567A GE AP2002005567 A GEAP2002005567 A GE AP2002005567A GE P20063882 B GEP20063882 B GE P20063882B
Authority
GE
Georgia
Prior art keywords
pharmaceutical composition
dosage regimen
emergency contraception
emergency
contraception
Prior art date
Application number
GE5567A
Other languages
English (en)
Inventor
Look Paul F A Van
Illesne Balogh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of GEP20063882B publication Critical patent/GEP20063882B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
GE5567A 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception GEP20063882B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (1)

Publication Number Publication Date
GEP20063882B true GEP20063882B (en) 2006-07-25

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
GE5567A GEP20063882B (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Country Status (33)

Country Link
US (1) US20050288264A2 (https=)
EP (1) EP1448207B1 (https=)
JP (1) JP2005516904A (https=)
KR (1) KR100908161B1 (https=)
CN (1) CN1551774A (https=)
AP (1) AP1849A (https=)
AT (1) ATE293978T1 (https=)
AU (1) AU2002347401A1 (https=)
BR (1) BR0210595A (https=)
CA (1) CA2450359C (https=)
DE (1) DE60203929T2 (https=)
DK (1) DK1448207T3 (https=)
EA (1) EA006545B1 (https=)
EC (1) ECSP045171A (https=)
ES (1) ES2239727T3 (https=)
GE (1) GEP20063882B (https=)
HR (1) HRP20040584B1 (https=)
HU (1) HU227198B1 (https=)
IL (1) IL159394A0 (https=)
IS (1) IS2691B (https=)
MA (1) MA27076A1 (https=)
MX (1) MXPA04005104A (https=)
NO (1) NO333984B1 (https=)
NZ (1) NZ530056A (https=)
OA (1) OA12730A (https=)
PL (1) PL206010B1 (https=)
PT (1) PT1448207E (https=)
RS (1) RS50768B (https=)
SI (1) SI1448207T1 (https=)
TN (1) TNSN04048A1 (https=)
UA (1) UA79942C2 (https=)
WO (1) WO2003045397A1 (https=)
ZA (1) ZA200404114B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
EP2365811A1 (en) * 2008-12-12 2011-09-21 Laboratoire HRA Pharma A method for contraception
BRPI1014035A2 (pt) 2009-04-14 2016-04-12 Hra Pharma Lab método para contracepção.
CN102458386B (zh) * 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
PL2741824T3 (pl) * 2011-08-11 2018-03-30 Estetra S.P.R.L. Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
EP2999469A1 (de) 2013-05-23 2016-03-30 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
KR100908161B1 (ko) 2009-07-16
BR0210595A (pt) 2004-06-08
DE60203929D1 (de) 2005-06-02
RS50768B (sr) 2010-08-31
PL206010B1 (pl) 2010-06-30
PT1448207E (pt) 2005-08-31
IS2691B (is) 2010-10-15
HUP0105173A2 (hu) 2003-08-28
MXPA04005104A (es) 2004-08-19
CA2450359A1 (en) 2003-06-05
HUP0105173D0 (en) 2002-02-28
EP1448207A1 (en) 2004-08-25
AU2002347401A1 (en) 2003-06-10
US20050288264A2 (en) 2005-12-29
NZ530056A (en) 2005-02-25
ECSP045171A (es) 2004-08-27
DE60203929T2 (de) 2006-01-19
EA200400731A1 (ru) 2004-12-30
JP2005516904A (ja) 2005-06-09
DK1448207T3 (da) 2005-06-27
EP1448207B1 (en) 2005-04-27
RS4204A (sr) 2007-02-05
IS7065A (is) 2003-12-05
CA2450359C (en) 2011-05-10
HU227198B1 (en) 2010-10-28
TNSN04048A1 (en) 2006-06-01
AP2004003046A0 (en) 2004-06-30
WO2003045397A1 (en) 2003-06-05
PL369520A1 (en) 2005-04-18
IL159394A0 (en) 2004-06-01
EA006545B1 (ru) 2006-02-24
ZA200404114B (en) 2005-10-26
HUP0105173A3 (en) 2004-03-29
AP1849A (en) 2008-05-23
CN1551774A (zh) 2004-12-01
UA79942C2 (en) 2007-08-10
ATE293978T1 (de) 2005-05-15
HRP20040584A2 (en) 2005-02-28
ES2239727T3 (es) 2005-10-01
HRP20040584B1 (en) 2012-11-30
SI1448207T1 (en) 2005-10-31
NO333984B1 (no) 2013-11-04
OA12730A (fr) 2006-06-28
MA27076A1 (fr) 2004-12-20
NO20041607L (no) 2004-04-20
US20050032755A1 (en) 2005-02-10
KR20040066088A (ko) 2004-07-23

Similar Documents

Publication Publication Date Title
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
HU9700589D0 (en) Extended release formulation
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
PL356358A1 (en) Solid dosage form of someticone for oral administration
BR0015188A (pt) Composições farmacêuticas
AU6089200A (en) Rapid immediate release oral dosage form
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
PT1411921E (pt) Composições farmacêuticas contendo terbinafina e suas utilizações
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
PL372457A1 (en) New pharmaceutical compositions containing flibanserin polymorph a
SG162605A1 (en) Pharmaceutical compositions
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
ZA200306545B (en) Medicinal compositions comprising diclofenac and ornoprostil.
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
MX2007009061A (es) Preparacion farmaceutica para la anticoncepcion oral.
AU2002212683A1 (en) Preventive or therapeutic medicines for hepatitis and/or hepatopathy
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
TW429144B (en) The pharmaceutical composition comprising the Con.A-Maltose complex and vehicle for oral use
AU2001293278A1 (en) Tableted oral extended release dosage form
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ